We have investigated the possibility that xanthine oxidase-linked free radical production has a role in the genesis of arrhythmias during ischemia and reperfusion. In this study, rats were treated with allopurinol (20 mg/kg, orally, 24 hours before study, plus 20 mg/kg, iv, 15 minutes prior to study). Using an anesthetized open-chest preparation with either coronary artery occlusion for 30 minutes, or 5 minutes followed by 10 minutes reperfusion, we monitored and compared the rhythm disturbances in experimental vs. placebo-treated rats (n = 18 in each group). Allopurinol treatment reduced the incidence of ventricular tachycardia during ischemia from 88% to 50% (P < 0.05) and the number of premature ventricular complexes from 471 ± 120 to 116 ± 46 (P < 0.02), but the treatment had no effect upon the incidence or duration of ventricular fibrillation or upon mortality. In contrast, far more dramatic protection was observed during reperfusion after 5 minutes of ischemia. Allopurinol treatment reduced the incidence of ventricular fibrillation from 67% to 11% (P < 0.01), reduced the mean duration of fibrillation from 230 ± 70 to 14 ± 1 seconds (P < 0.05), and reduced mortality by half (10/18 to 4/18), although this did not reach a level of statistical significance. In addition, the mean duration of tachycardia was reduced from 83 ± 26 to 38 ± 8 seconds (P < 0.05). Allopurinol pretreatment thus affords some protection against ischemia-induced arrhythmias, but a higher degree of protection against reperfusion-induced arrhythmias. Allopurinol inhibits xanthine oxidase activity, and, in turn, this inhibits superoxide radical production. Since free radical generation has been implicated in the genesis of tissue injury during ischemia and reperfusion, and since the severity of this injury can influence vulnerability to both ischemia and reperfusion-induced arrhythmias, we would propose that free radical formation by xanthine oxidase, or its consequences, is a new factor to consider in relation to the vulnerability of tissue to ischemia and reperfusion-induced arrhythmias. (CircRes 55: 545-548, 1984) 
XANTHINE oxidase activity is a major potential source of superoxide radical (C>2~)/ and it has been proposed (McCord, 1984) that free radical production, particularly by xanthine oxidase, plays an important role in the genesis of ischemic injury and, more especially, reperfusion-induced injury. Supporting this concept is the observation that the specific inhibitor of xanthine oxidase activity, allopurinol, reduces reperfusion-induced tissue injury (Fabiani, 1976 ). In addition, free radical scavengers (for example, ascorbate, vitamin E, superoxide dismutase, catalase, and mannitol) can reduce tissue injury caused by hypoxia and reoxygenation (Gauduel and Duvelleroy, 1984) .
An important consequence of both myocardial ischemia and reperfusion is the occurrence of various disturbances of cardiac rhythm, including the potentially lethal condition of ventricular fibrillation (Corr and Witkowski, 1983; Manning and Hearse, 1984) . The realization that reperfusion is a clinically relevant phenomenon (for example, with the spontaneous relief of coronary artery spasm, with fibrinolysis and angioplasty, and with ischemic arrest during cardiac surgery) and the fact that it might precipitate lethal arrhythmias has stimulated great interest in the genesis and control of reperfusion arrhythmias. A variety of molecular factors have been implicated as primary triggers leading to the occurrence of arrhythmias, and they all represent various aspects (e.g., membrane damage and ionic imbalance) of the complex process of cellular injury. In this connection, it is now well established that the duration and severity of tissue injury is a critical determinant of the vulnerability of tissue to arrhythmias during both ischemia and reperfusion. It is similarly well established that agents which modify tissue injury greatly alter the extent of arrhythmias. Since free radical production is now thought to be a major factor in the evolution of tissue injury, and these intermediates are thought to be capable of causing severe membrane damage, it would seem possible that inhibition of free radical production might represent a potent means of preventing serious cardiac rhythm disturbances. During the investigation of this possibility, we have exploited the ability of allopurinol to inhibit xanthine oxidase activity. The ability of xanthine oxidase to catalyze the conversion of hypoxanthine to xanthine and uric acid represents a major potential source of superoxide radicals during ischemia. However, during early reperfusion, there is potentially a far greater production and role for free radicals, when large amounts of hypoxanthine may be generated from adenine nucleotide breakdown, when the conversion of xanthine dehydrogenase to xanthine oxidase is stimulated, and when a number of naturally occurring mechanisms for free radical scavenging are impaired (McCord, 1984) . We have therefore compared the ability of allopurinol to influence the severity of ischemia and reperfusion-induced arrhythmias using an anesthetized open-chest rat preparation with temporary coronary artery occlusion.
Methods

Animals
Male rats of the Wistar strain (250-350 g body weight) were used, and 18 animals were studied in each treatment group.
Experimental Protocol
Allopurinol (20 mg/kg body weight) was administered, orally, 24 hours prior to investigation, and a second similar dose was given intravenously via the femoral vein 15 minutes prior to coronary occlusion, after the animals had been anesthetized with sodium pentabarbitone (Sagatal). Animals were ventilated with room air, using a stroke volume of approximately 20 ml/kg body weight and at a rate of 55 strokes/min. Body temperature was maintained with a heated operating platform and appropriate heating lamps. Body temperature was routinely monitored via a rectal thermometer. The electrocardiogram (ECG) was recorded via standard limb leads.
The chest was opened by a left thoracotomy and, using a technique developed by Fabiani et al. (1977) , the heart was gently exteriorized by pressure on the abdomen. A ligature was then placed around the left anterior descending coronary artery, close to its origin. The heart was then replaced within the thoracic cavity with the ligature ends exteriorized. At this point, any animals exhibiting significant ventricular arrhythmias were discarded from the study.
For the study of arrhythmias induced by ischemia, both ends of the ligature were passed through a small plastic tube which was then pressed on the surface of the heart directly above the left anterior descending artery. The resulting arterial occlusion was maintained for 30 minutes by clamping the plastic tube and ligature with small hemostats.
For the study of reperfusion-induced arrhythmias, the left anterior descending coronary artery was occluded in an identical manner for 5 minutes. Reperfusion was then achieved by removing the clamp and tube. Rhythm disturbances were then monitored for a further 10 minutes.
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Measurement of Hemodynamic Changes
To measure any possible effects of allopurinol on heart rate and blood pressure, a separate series of allopurinoltreated animals (n = 5) and placebo-treated animals were anesthetized and the carotid artery catheterized. The catheter was attached to a pressure transducer, and measurements of blood pressure were monitored on a Gould Physiograph throughout a 30-minute period of coronary artery occlusion, performed as described in the preceding section. Values for heart rate were calculated from the blood pressure trace.
Validation of Coronary Occlusion and Reperfusion
Evans Blue dye was administered intravenously, to ensure that occlusion and reperfusion had been adequately accomplished. If administered after 30 minutes of coronary artery occlusion, the generation of an area of regional ischemia would be confirmed by a nonstained area of myocardium. To ensure that reperfusion had occurred, the dye was routinely administered at the end of the 10-minute reperfusion period. A uniformly stained heart was evidence that reperfusion had occurred; no cases were noted of reperfusion not occuring upon release of the ligature after 5 minutes of ischemia. Further evidence of successful occlusion and reperfusion was available from the accompanying electrocardiographical changes.
Evaluation of Rhythm Disturbances
High-speed electrocardiograms were permanently recorded on a Gould Physiograph and analyzed for (1) the number of premature ventricular complexes (PVC's), (2) the incidence and duration of ventricular fibrillation (VF), and (3) the incidence and duration of ventricular tachycardia (VT), defined as five or more consecutive PVC's.
Tests of Statistical Significance
The paired Mest was used to determine the significance of differences, and results are shown as the mean ± 1 SEM.
Distributions of discrete variables were compared by the modified x 2 distribution, using the Yates correction.
Results
Hemodynamic Changes during Coronary Artery Occlusion
In placebo-treated control animals, heart rate throughout a 30-minute period of coronary artery occlusion remained constant, such that after 5, 15, and 30 minutes, heart rate was 480 ± 21, 478 ± 14 and 490 ± 1 2 beats/min. Treatment with allopurinol did not affect heart rate, and values at the same time points were 504 ± 1 5 , 486 ± 1 2 , and 480 ± 21 beats/min. Similarly, blood pressure measurements during coronary artery occlusion were not significantly altered. Values of peak systolic/end-diastolic pressure after 5, 15, and 30 minutes were 118 ± 19/ 95 ± 22, 128 ± 11/105 ± 12, and 110 ± 10/88 ± 10 mm Hg in the placebo-treated group, and 137 ± 12/ 113 ± 14, 132 ± 15/108 ± 14, and 129 ± 11/97 ± 14 mm Hg in the allopurinol-treated group.
Ischemia-Induced Rhythm Disturbances
In placebo-treated control animals, severe ventricular arrhythmias began after 4-5 minutes of coronary artery occlusion, peaked after 10 minutes, and had normally subsided by approximately 18 minutes. In the control group (n = 18), the mean time to onset of ventricular fibrillation was 303 ± 101 seconds, and the mean time to onset of ventricular tachycardia was 344 ± 32 seconds. As shown in Table 1 , 50% of animals exhibited ventricular fibrillation, whereas almost 90% exhibited ventricular tachycardia.
Allopurinol treatment had no significant effect on the incidence of ventricular fibrillation, the duration of ventricular fibrillation, or the duration of ventricular tachycardia, and-of particular importance-it had no effect upon mortality. However, the incidence of ventricular tachycardia was reduced from 89% to 50% (P < 0.05), and the total premature ventricular complexes (in those animals surviving the 30-minute period of coronary artery occlusion) was reduced from 471 ± 128 to 116 ± 46 (P < 0.02).
Reperfusion-Induced Rhythm Disturbances
We and others (for review, see Manning and Hearse, 1984) have shown that, in a number of species, vulnerability to reperfusion-induced arrhythmias is critically dependent upon the duration of the preceding period of ischemia. Thus, in attempting to assess the ability of any agent to modify reperfusion arrhythmias, the selection of the duration of preceding ischemia can be critical. For the present studies, we selected a 5-minute period of ischemia followed by a 10-minute period of reperfusion. This choice was based on an earlier characterization study (Manning and Hearse, 1984) using the identical preparation, in which we demonstrated that a 5-minute period of ischemia produced the highest incidence of rhythm disturbances, and all major reperfusion-induced arrhythmias (such as fibrillation and tachycardia) had occurred within a 10-minute reperfusion period. Table 2 shows that, in placebo-treated control animals, the severity of reperfusion-induced arrhythmias tended to be greater than that observed during ischemia (Table 1) . Thus, for example, almost 70% of animals exhibited ventricular fibrillation in the reperfusion series, and this lasted much longer than during ischemia. As a consequence, over 50% of rats died, mainly from ventricular fibrillation.
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Allopurinol treatment resulted in a drastic reduction in the incidence of ventricular fibrillation (67% to 11%; P < 0.01) and in the mean duration of ventricular fibrillation (230 ± 70 to 14 ± 1 seconds). It also reduced the duration of ventricular tachycardia to approximately one-third of that seen in the control group (93 ± 26 to 34 ± 8 seconds; P < 0.05). Allopurinol treatment also halved mortality from 56% to 22%, although this did not reach a level of statistical significance.
Discussion
In seeking to define mechanisms underlying the genesis of serious ventricular arrhythmias (particularly ventricular fibrillation) during both ischemia and reperfusion, it is probably fair to state that the establishment of reentry circuits and possibly enhanced automaticity are the ultimate electrophysiological aberations responsible for the manifestation of the arrhythmia. It is equally well established that regional heterogeneity of tissue injury or recovery is probably a critical progenitor for the establishment of reentry circuits. What remains to be established is which of the many complex molecular changes occurring during ischemia or reperfusion is critical to the limitation of electrophysiological instability. In recent years, many processes have been suggested as potential culprits (for review, see Opie et al., 1978; Corr and Witkowski, 1982; Manning and Hearse, 1984) . These include unfavorable redistribution and accumulation of ions, particularly potassium and calcium, the release of catecholamines, cAMP, changes in the availability of glycolytically produced ATP, the accumulation and utilization of fatty acids, the activity of membrane lysophosphatides, and the activity of the a-receptor. To this list of potential arrhythmogenic molecular changes, we would add the production of free radicals as a consequence of the activity of the enzyme xanthine oxidase.
In the present study, we have shown that the administration of allopurinol prior to coronary artery occlusion and reperfusion in an anesthetized in vivo rat preparation reduces significantly the incidence and severity of ischemia-induced arrhythmias and dramatically reduces reperfusion-induced arrhythmias and mortality. Extrapolating this observation to the level of free radical formation must of course be carried out with great caution, since we have not directly measured these short-lived molecular intermediates, and in this preliminary study we have not measured or demonstrated any change in the activity or ratio of xanthine dehydrogenase and xanthine oxidase. Despite this clear limitation, we would argue that certain other criteria support our association of arrhythmogenic effects with a reduction of free radical formation. First, allopurinol is a highly specific inhibitor of the xanthine oxidase system (McCord, 1984) . Second, free radical formation will occur under conditions of ischemia, despite the reduced availability of oxygen (Rao et al., 1983) . However, we would hypothesize that far greater production of the superoxide radical would occur upon reperfusion with the return of oxygen at much higher concentrations. This fact, together with our observation that reperfusion arrhythmias are (1) more severe and (2) more amenable to reduction by allopurinol than ischemia-induced arrhythmias, strengthens the association between free radicals and arrhythmias. Third, in a recent study, Woodward and Zakaria (in press) reported that the free radical scavenger superoxide dismutase can effectively reduce reperfusion arrhythmias in the rat. If free radical formation is to initiate a sequence of events leading to an arrhythmia, it is necessary to ask whether this is some direct electrical effect of these charged intermediates or do they act via some intermediate process? At the present time, this question cannot be definitively answered, but we would advance our view that perturbation of membrane integrity and function is a key link in the induction of tissue injury and the expression of this tissue damage as an arrhythmia. Since it is well known (McCord, 1984) that free radicals can cause major membrane damage by peroxidation of component phospholipids, the most likely effect of free radicals is to alter membrane structure and the membrane's ability to control ionic shifts.
In conclusion, evidence is presented that superoxide radical production from xanthine oxidase may play an important role in the genesis of reperfusioninduced arrhythmias and a lesser role in the genesis of ischemia-induced arrhythmias, and that effective pharmacological control of reperfusion arrhythmias, particularly the potentially lethal rhythm disturbance ventricular fibrillation, might be accomplished either by inhibitors of free radical formation or by the use of selective scavengers.
